Biohaven Ltd (NY: BHVN )
23.85 +0.72 (+3.11%) Official Closing Price Updated: 7:00 PM EDT, Jun 9, 2023 Add to My Watchlist
All News about Biohaven Ltd
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
October 03, 2022
From Pfizer Inc.
Via Business Wire
Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months
September 29, 2022
Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).
Stocks That Hit 52-Week Highs On Friday
September 23, 2022
Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know
August 23, 2022
Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
August 19, 2022
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following